Drug recall · October 16, 2019
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection recall
Why: Lack of Assurance of Sterility: Bag has the potential to leak.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
10% LMD in 5% Dextrose Injection Dextran 40 in Dextrose Injection, USP, 500 mL bags, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7418-13
- Lots / codes
Lot #: 87-095-JT Exp. 1MAR2020
- Quantity
- 17832 bags
- Company
- Pfizer Inc., New York, NY
- Distribution
- Nationwide in the United States and Puerto Rico
- Initiated
- October 2, 2019 · Voluntary: Firm initiated
- Classified
- October 9, 2019
- Reported
- October 16, 2019
- Ended
- December 1, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dextran 40
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.